Learn / LNTH
NASDAQ: LNTH
Lantheus Holdings (LNTH) stock, explained like you're 5
Lantheus Holdings trades on the Nasdaq under the ticker LNTH. It is a mid cap company in the in vitro & in vivo diagnostic substances industry, part of the healthcare sector, with a market value of about 6.5 billion dollars.
- Ticker
- LNTH
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Size
- Mid cap, about 6.5 billion dollars
Is Lantheus Holdings a small, medium or large cap company?
No. Lantheus Holdings is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 6.5 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Lantheus Holdings makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves LNTH stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- LNTH Stock Drops After Hours As Curium's $7B Offer Comes In Below Market Value (Stocktwits)
- Lantheus Holdings (LNTH) Stock May Be 14% Undervalued On FDA Approval (Yahoo Finance)
- Lantheus Holdings (LNTH) Could Be 7% Undervalued As Its Pipeline Story Builds (Simply Wall Street)
- LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders (Business Wire)
- Why Lantheus Holdings Stock Popped by Almost 12% Last Month (The Motley Fool)
Follow LNTH in your daily brief
Each trading day at 5 PM ET we post what happened to Lantheus Holdings and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow LNTH
Questions about Lantheus Holdings stock
What does Lantheus Holdings do?
Lantheus Holdings trades on the Nasdaq under the ticker LNTH. It is a mid cap company in the in vitro & in vivo diagnostic substances industry, part of the healthcare sector, with a market value of about 6.5 billion dollars.
What is the ticker symbol for Lantheus Holdings?
Lantheus Holdings trades under the ticker LNTH on the Nasdaq.
What is Lantheus Holdings's market cap?
Lantheus Holdings is a mid cap stock with a market cap of about 6.5 billion dollars.
How does Lantheus Holdings make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves LNTH stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow LNTH stock every day?
Add LNTH to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.